Sionna Therapeutics, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | – | |
| – | +377.9% | +14.6% | -556.9% | |
| – | +34.0% | +64.1% | +225.4% | |
| – | -128.3% | – | – | |
| – | -40.4% | -97.6% | +1,296.3% | |
| – | – | -564.0% | -6.4% | |
| – | -100.0% | +577,212.9% | +14.9% | |
| – | -135.8% | – | – | |
| – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.